Document Detail


The psychomotor development of full term infants whose mothers were treated with glucocorticosteroids during pregnancy.
MedLine Citation:
PMID:  3640328     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Development Quotient (D.Q.) was tested in 48 full term infants at the ages of 12-24 months who had been treated antenatally with Betamethasone to hasten pulmonary maturity. The results were compared with a control group of 100 normal full term infants of the same age. Although the two groups differed with respect to gestational age, there were no differences in birth weight, Apgar score and method of delivery between them. The results of the D.Q. evaluation showed no significant difference between the two groups. The assumption is made, therefore, that antenatal treatment with Glucocorticosteroids in the second and third trimester does not adversely affect the infant's psychological and motor development.
Authors:
S Levin; A Robinson; H Zakut
Related Documents :
25311608 - Sociodemographic differences and infant dietary patterns.
2419088 - Development of visual evoked potentials and photic driving responses in normal full ter...
20623118 - Reversible pituitary hyperplasia at birth in a macrosomic full-term baby boy.
11383998 - Current status of fascia lata allograft slings treating urinary incontinence: effective...
15513578 - Assessment of jaundice in preterm neonates: comparison between clinical assessment, two...
3596838 - The value of counter-current aortography in infants.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pädiatrie und Pädologie     Volume:  21     ISSN:  0030-9338     ISO Abbreviation:  Padiatr Padol     Publication Date:  1986  
Date Detail:
Created Date:  1986-12-09     Completed Date:  1986-12-09     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0022370     Medline TA:  Padiatr Padol     Country:  AUSTRIA    
Other Details:
Languages:  eng     Pagination:  233-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Betamethasone / adverse effects*,  therapeutic use
Child Development / drug effects
Female
Fetal Organ Maturity / drug effects*
Humans
Hyaline Membrane Disease / prevention & control*
Infant
Infant, Newborn
Lung / embryology*
Motor Skills / drug effects
Pregnancy
Prenatal Exposure Delayed Effects*
Psychomotor Performance / drug effects*
Chemical
Reg. No./Substance:
378-44-9/Betamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic expression of complement factors and alpha 1-acid glycoprotein by liver tissue during senesc...
Next Document:  Serum thyroglobulin levels in preterm infants with and without respiratory distress syndrome. II. A ...